Acid-fast bacilli persisting in the genitourinary tract 3 years after intravesical bacille Calmette-Guerin therapy for bladder carcinoma

British Journal of Urology

Volumn 81, Issue 3, 1998, Pages 496-497

  Hurle, R ^a   Losa, A ^a   Ranieri, A ^a   Lembo, A ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOMODULATING AGENT; ISONIAZID; PREDNISOLONE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER IMMUNOTHERAPY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CYSTECTOMY; CYSTOSCOPY; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TUMOR RECURRENCE; URINARY TRACT INFECTION; URINE CULTURE;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; BCG VACCINE; CARCINOMA IN SITU; HUMANS; ISONIAZID; MALE; RIFAMPIN; TUBERCULOSIS, MALE GENITAL; URINARY BLADDER NEOPLASMS;

EID: 0031817339     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1998.00578.x     Document Type: Article

References (4)

1. Lamm DL, Blumenstein BA. Crawford ED et al. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional cell carcinoma of the bladder. N Engl J Med 1991: 325: 1205-9
2. Orihuela E, Herr HW, Pinsky CM, Whitmore WF], Toxicity of intravesical BCG and its management in patients with superficial bladder tumors. Cancer 1987: 60: 326-33
3. Lamm LD, van der Meijden APM. Morales A et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992: 147: 596-600
4. Steg A, Leleu C, Debre B. Boccon-Gibod L. Sicard D. Systemic bacillus Calmette Guerin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guerin therapy for bladder cancer. Eur Urol 1989; 16: 161-4